AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
Patrick Mahomes penned essay ahead of 2017 Draft telling teams why they should pick him. Those words proved to be true.
AI chip stock Arm Holdings surged more than 152% past a recent buy point. Following that advance, is Arm stock a buy in today's stock market?